US Stock Market Move | New stock Turn Therapeutics (TTRX.US) surges over 144%, dedicated to developing next-generation therapies for skin diseases, wounds, and infections.
As of press time, the stock has risen over 144%, reaching $16.95.
On Thursday, the stock price of the newly established company Turn Therapeutics (TTRX.US) rose by over 144%, reaching $16.95 as of the time of writing. Turn Therapeutics is committed to developing next-generation therapies for skin diseases, wounds, and infections. The company has a proprietary delivery platform technology called "PermaFusion," which is designed to allow water-soluble active ingredients to penetrate the skin, nails, or mucous membranes with an oily carrier without the need for emulsifiers, thereby enhancing availability and reducing irritation.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
